These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 34963428

  • 1. 18[Formula: see text]-Glycyrrhetinic Acid Inhibits TGF-[Formula: see text]-Induced Epithelial-to-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma by Targeting STAT3.
    Jie M, Zhang ZQ, Deng N, Liu QM, Wang C, Ge QY, Du PC, Song SS, Zhang XW, Long-Xin, Liang HF, Chu L, Zhang L, Chen XP, Chen J, Dong HH, Zhang BX.
    Am J Chin Med; 2022; 50(1):313-332. PubMed ID: 34963428
    [Abstract] [Full Text] [Related]

  • 2. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
    Wang B, Liu T, Wu JC, Luo SZ, Chen R, Lu LG, Xu MY.
    Biomed Pharmacother; 2018 Feb; 98():214-221. PubMed ID: 29268242
    [Abstract] [Full Text] [Related]

  • 3. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
    Kim YJ, Jeon Y, Kim T, Lim WC, Ham J, Park YN, Kim TJ, Ko H.
    Bioorg Med Chem Lett; 2017 Feb 15; 27(4):1081-1088. PubMed ID: 28110870
    [Abstract] [Full Text] [Related]

  • 4. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
    Yang Y, Liu Q, Li Z, Zhang R, Jia C, Yang Z, Zhao H, Ya S, Mao R, Ailijiang T, Bao Y, Zhang H.
    Carcinogenesis; 2018 Jul 03; 39(7):900-910. PubMed ID: 29365054
    [Abstract] [Full Text] [Related]

  • 5. SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan LC, Shiau CW, Tai WT, Hung MH, Chu PY, Hsieh FS, Lin H, Yu HC, Chen KF.
    Oncogene; 2015 Oct 08; 34(41):5252-63. PubMed ID: 25619838
    [Abstract] [Full Text] [Related]

  • 6. FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling.
    Yang G, Liang Y, Zheng T, Song R, Wang J, Shi H, Sun B, Xie C, Li Y, Han J, Pan S, Lan Y, Liu X, Zhu M, Wang Y, Liu L.
    Cancer Lett; 2016 Aug 10; 378(2):80-6. PubMed ID: 27177473
    [Abstract] [Full Text] [Related]

  • 7. MEF2 transcription factors promotes EMT and invasiveness of hepatocellular carcinoma through TGF-β1 autoregulation circuitry.
    Yu W, Huang C, Wang Q, Huang T, Ding Y, Ma C, Ma H, Chen W.
    Tumour Biol; 2014 Nov 10; 35(11):10943-51. PubMed ID: 25087096
    [Abstract] [Full Text] [Related]

  • 8. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.
    Chen J, Zhu H, Liu Q, Ning D, Zhang Z, Zhang L, Mo J, Du P, Liu X, Song S, Fan Y, Liang H, Liu J, Zhang B, Chen X.
    J Exp Clin Cancer Res; 2019 Jun 22; 38(1):273. PubMed ID: 31228948
    [Abstract] [Full Text] [Related]

  • 9. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG.
    Hepatology; 2013 Oct 22; 58(4):1349-61. PubMed ID: 23696034
    [Abstract] [Full Text] [Related]

  • 10. Platelets promote primary hepatocellular carcinoma metastasis through TGF-β1-mediated cancer cell autophagy.
    Lu M, Gong X, Zhang YM, Guo YW, Zhu Y, Zeng XB, Gao JH, Liu LM, Shu D, Ma R, Liang HF, Zhang RY, Xu Y, Zhang BX, Lu YJ, Ming ZY.
    Cancer Lett; 2024 Sep 28; 600():217161. PubMed ID: 39117067
    [Abstract] [Full Text] [Related]

  • 11. The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway.
    Wang J, Yin D, Xie C, Zheng T, Liang Y, Hong X, Lu Z, Song X, Song R, Yang H, Sun B, Bhatta N, Meng X, Pan S, Jiang H, Liu L.
    Oncotarget; 2014 Sep 30; 5(18):8478-91. PubMed ID: 25261367
    [Abstract] [Full Text] [Related]

  • 12. STAT3 activation mediates epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang CH, Guo FL, Xu GL, Jia WD, Ge YS.
    Hepatogastroenterology; 2014 Jun 30; 61(132):1082-9. PubMed ID: 26158169
    [Abstract] [Full Text] [Related]

  • 13. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X, Zhang BH, Zheng SS, Gao DM, Qiu SJ, Wu WZ, Ren ZG.
    J Hematol Oncol; 2015 Mar 11; 8():23. PubMed ID: 25879771
    [Abstract] [Full Text] [Related]

  • 14. Immune checkpoint molecules are regulated by transforming growth factor (TGF)-β1-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Shrestha R, Bridle KR, Crawford DHG, Jayachandran A.
    Int J Med Sci; 2021 Mar 11; 18(12):2466-2479. PubMed ID: 34104078
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
    Malfettone A, Soukupova J, Bertran E, Crosas-Molist E, Lastra R, Fernando J, Koudelkova P, Rani B, Fabra Á, Serrano T, Ramos E, Mikulits W, Giannelli G, Fabregat I.
    Cancer Lett; 2017 Apr 28; 392():39-50. PubMed ID: 28161507
    [Abstract] [Full Text] [Related]

  • 16. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
    Wang J, Fan Z, Li J, Yang J, Liu X, Cheng J.
    Bioengineered; 2021 Dec 28; 12(1):3566-3577. PubMed ID: 34281492
    [Abstract] [Full Text] [Related]

  • 17. ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling.
    Huang Y, Zhou B, Luo H, Mao J, Huang Y, Zhang K, Mei C, Yan Y, Jin H, Gao J, Su Z, Pang P, Li D, Shan H.
    Theranostics; 2019 Dec 28; 9(15):4391-4408. PubMed ID: 31285768
    [Abstract] [Full Text] [Related]

  • 18. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY, Zeng Y, Lei Z, Wang L, Yang H, Liu Z, Zhao J, Zhang HT.
    Int J Oncol; 2014 May 28; 44(5):1643-51. PubMed ID: 24573038
    [Abstract] [Full Text] [Related]

  • 19. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition.
    Xu S, Zhang ZH, Fu L, Song J, Xie DD, Yu DX, Xu DX, Sun GP.
    Cancer Sci; 2020 Jan 28; 111(1):59-71. PubMed ID: 31729097
    [Abstract] [Full Text] [Related]

  • 20. DYRK1A reinforces epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via cooperatively activating STAT3 and SMAD.
    Li YL, Zhang MM, Wu LW, Liu YH, Zhang ZY, Zeng LH, Lin NM, Zhang C.
    J Biomed Sci; 2022 Jun 02; 29(1):34. PubMed ID: 35655269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.